{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:27:24Z","timestamp":1791336444971,"version":"4.3.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/jgp.0b013e3181ca3a4e","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T06:44:31Z","timestamp":1269326671000},"page":"606-614","source":"Crossref","is-referenced-by-count":14,"title":["Effect of Memantine Treatment on Regional Cortical Metabolism in Alzheimer's Disease"],"prefix":"10.1016","volume":"18","author":[{"given":"David L.","family":"Sultzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Melrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan G.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Mandelkern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archneur.65.8.1031","article-title":"Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease","volume":"65","author":"Fleisher","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.WNL.0000042480.86872.03","article-title":"MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD","volume":"60","author":"Jack","year":"2003","journal-title":"Neurology"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","article-title":"The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease","volume":"9","author":"Rogawski","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2014too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib7","series-title":"Dementia","first-page":"433","article-title":"Abnormalities in non-cholinergic neurotransmitter systems in Alzheimer's disease","author":"Procter","year":"2000"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib8","first-page":"191","article-title":"Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease","volume":"77","author":"Minkeviciene","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib9","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1259\/bjr\/97295129","article-title":"Positron emission tomography imaging in dementia","volume":"80","author":"Herholz","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib10","first-page":"1625","article-title":"Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET","volume":"46","author":"Drzezga","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib11","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/archneur.62.11.1728","article-title":"Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease","volume":"62","author":"Anchisi","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib12","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1176\/appi.neuropsych.16.4.488","article-title":"One-year change in cerebral glucose metabolism in patients with Alzheimer's disease","volume":"16","author":"Hirono","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1176\/appi.ajp.160.2.341","article-title":"Delusional thoughts and regional frontal\/temporal cortex metabolism in Alzheimer's disease","volume":"160","author":"Sultzer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/gps.2229","article-title":"The neural correlates of naming and fluency deficits in Alzheimer's disease: a FDG-PET study","volume":"24","author":"Melrose","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00702-005-0312-6","article-title":"Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease","volume":"113","author":"Stefanova","year":"2006","journal-title":"J Neural Transm"},{"issue":"suppl 2","key":"10.1097\/JGP.0b013e3181ca3a4e_bib17","doi-asserted-by":"crossref","first-page":"T786","DOI":"10.1016\/j.jalz.2008.05.2454","article-title":"Tau aggregation inhibitor therapy with Rember changes glucose metabolism in the medial temporal lobes in mild and moderate Alzheimer's disease","volume":"4","author":"Murray","year":"2008","journal-title":"Alzheimer Dementia"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d: A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib20","series-title":"Dementia Rating Scale: Professional Manual","author":"Mattis","year":"1988"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.1992.tb02101.x","article-title":"Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale","volume":"40","author":"Sultzer","year":"1992","journal-title":"J Am Geriatr Soc"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib22","series-title":"Handbook of Psychiatric Measures","first-page":"407","article-title":"Dementia rating scale","author":"Mattis","year":"2008"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-3956(95)00018-Z","article-title":"The Neurobehavioral Rating Scale: reliability in patients with dementia","volume":"29","author":"Sultzer","year":"1995","journal-title":"J Psychiatr Res"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib24","first-page":"235","article-title":"Efficient stereospecific synthesis of no-carrier-added 2\u201318F-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution","volume":"27","author":"Hamacher","year":"1986","journal-title":"J Nucl Med"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","article-title":"An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets","volume":"19","author":"Maldjian","year":"2003","journal-title":"Neuroimage"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","article-title":"Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies","volume":"159","author":"Alexander","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S1461145701002528","article-title":"Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease","volume":"4","author":"Potkin","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00842779","article-title":"Reproducibility of cerebral glucose utilization measured by PET and the 18F-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects","volume":"16","author":"Maquet","year":"1990","journal-title":"Eur J Nucl Med"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archneur.62.5.721","article-title":"Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study","volume":"62","author":"Mega","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib30","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/jnnp.2007.141648","article-title":"Memantine effects on brain volume, glucose metabolism and cognition in AD patients\u2014a randomized, double-blind, placebo-controlled neuroimaging pilot study","volume":"79","author":"Schmidt","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib31","unstructured":"Weiner M, Graham SM, Hofbauer RK, et al: Memantine treatment in patients with Alzheimer's disease is associated with a slower right hippocampal volume loss: an open-label, multi-center trial. Presented at the International Conference on Alzheimer's Disease. Chicago, IL, 2008."},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02815108","article-title":"Modifications of neuronal phosphorylated tau immunoreactivity induced by NMDA toxicity","volume":"27","author":"Couratier","year":"1996","journal-title":"Mol Chem Neuropathol"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.mnm.0000189783.39411.ef","article-title":"Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography","volume":"27","author":"Hirao","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.55.3.190","article-title":"Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease","volume":"55","author":"Jobst","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/brain\/awm288","article-title":"Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease","volume":"131","author":"Chetelat","year":"2008","journal-title":"Brain"},{"key":"10.1097\/JGP.0b013e3181ca3a4e_bib36","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/brain\/122.8.1519","article-title":"Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease","volume":"122","author":"Meguro","year":"1999","journal-title":"Brain"},{"issue":"suppl 1","key":"10.1097\/JGP.0b013e3181ca3a4e_bib37","doi-asserted-by":"crossref","first-page":"S619","DOI":"10.1016\/j.jalz.2006.05.2089","article-title":"Regional cortical metabolism and medication treatment response in Alzheimer's disease","volume":"2","author":"Sultzer","year":"2006","journal-title":"Alzheimer Dementia"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112600724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112600724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T11:23:17Z","timestamp":1544613797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748112600724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1064748112600724"],"URL":"https:\/\/doi.org\/10.1097\/jgp.0b013e3181ca3a4e","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}